CRNX
|
Crinetics Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
CTSO
|
Cytosorbents Corporation
|
US
|
NASDAQ
|
CVS
|
CVS Caremark Corporation
|
US
|
NYSE
|
CYCN
|
Cyclerion Therapeutics, Inc.
|
US
|
NASDAQ
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
DVA
|
DaVita HealthCare Partners Inc.
|
US
|
NYSE
|
DYN
|
Dyne Therapeutics, Inc.
|
US
|
NASDAQ
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
ELAT
|
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
|
US
|
NYSE
|
ELMD
|
Electromed, Inc.
|
US
|
AMEX
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|
EVOK
|
Evoke Pharma, Inc.
|
US
|
NASDAQ
|
FENC
|
Fennec Pharmaceuticals Inc.
|
US
|
NASDAQ
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|
FRTX
|
Fresh Tracks Therapeutics
|
US
|
NASDAQ
|
FULC
|
Fulcrum Therapeutics, Inc.
|
US
|
NASDAQ
|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
GH
|
Guardant Health, Inc.
|
US
|
NASDAQ
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|